Stock Institutional Ownership and Shareholders

SecurityCOCP / Cocrystal Pharma, Inc. (19188J102)
INTERIM CEOWILCOX GARY
Institutional Owners2
Institutional Shares105,000
Outstanding Shares728,032,000 (as of 2017-09-30)
Institutional Value$ 28,000 USD

Cocrystal Pharma, Inc. (OTC:COCP) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 105,000 shares. Largest shareholders include MAI Capital Management, and Highlander Capital Management, LLC.



Cocrystal Pharma, Inc. (OTC:COCP) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-10-12 13F-HR MAI Capital Management 85,000 85,000 0.00 19 23 21.05
2017-11-15 13F-HR Highlander Capital Management, LLC 20,000 20,000 0.00 4 5 25.00
CUSIP: 19188J102